Integrated into your electronic health record, every time you write a prescription ActX checks the drug against your patient's genetics, alerting you if there's an issue with adverse drug reactions, efficacy, or dosing. ActX covers most common U.S. prescription drugs.

Almost 90% of patients carry variants that affect medications. Based on the ActX curated KnowledgeBase of the latest published clinical studies, you will be able to:

• Avoid serious adverse reactions such as Stevens-Johnson syndrome or syncope
• Prescribe an effective drug immediately rather than waiting a month or two to discover that the drug was ineffective and must be changed
• Individualize dosing for selected medications

The ActX patient genomic profile shows actionable patient genomic risks for cancer, cardiac disease, metabolic disease and other conditions that often are not identifiable from family history and are asymptomatic.

Around 3% of patients have serious hereditary risks. About 20% of patients have genetic risk factors which are less serious and typically need another factor to become a serious risk.

For example, patients with Lynch Syndrome, a genetic condition affecting hundreds of thousands of Americans, can have up to a 70% lifetime risk of colorectal cancer, and begin colonoscopy screening at age 25 or 30.

ActX's carrier status panel now includes more than 250 conditions. This can help your clinicians provide your patients information about the risk of parents passing on serious recessive genetic conditions to their children.

60% of your patients who plan to have children will have at least one genetic condition they may pass on to their children.

ActX information is continuously updated and includes references. Our system evaluates the strength of the evidence and the quality of the patient data. Existing patient genetic data is frequently reanalyzed and your clinicians will be alerted if an important new issue is found for a patient. ActX can be accessed via your EHR or directly on the ActX website.